论文部分内容阅读
恶性胸水是晚期恶性肿瘤常见的并发症之一 ,自1995年以来 ,我们应用TIL细胞联合IL 2治疗恶性胸水 32例 ,取得了满意效果 ,报道如下 :①临床资料 :本组共 32例 ,男 2 0例 ,女 12例 ,年龄 4 1~ 69岁 ,中位年龄 57岁 ,原发肺癌 19例 ;其中小细胞肺癌 11例 ;非小细胞肺癌 8例
Malignant pleural effusion is a common complication of advanced malignant tumors, since 1995, we use TIL cells in combination with IL 2 in 32 cases of malignant pleural effusion, and achieved satisfactory results reported as follows: ① clinical data: a total of 32 patients in this group, male 20 patients, 12 females, aged 41-69 years, with a median age of 57 years old, 19 cases of primary lung cancer; 11 cases of small cell lung cancer; 8 cases of non-small cell lung cancer